Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study

Paola Savoia1, Michela Ortoncelli, Pietro Quaglino

  • 1Department of Medical Sciences and Human Oncology, Section of Dermatology, University of Turin, Turin, Italy. paolo.saviola@unito.it

Abstract

No abstract available in PubMed .